Clinical Trial Update: A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of zidovudine in infants exposed to HIV before or shortly after birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• RETROVIR (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED